NCT06959108
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06959108
Title Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck (IDEAL)
Acronym IDEAL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Groupe Oncologie Radiotherapie Tete et Cou
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.